Treating thrombocytopenia depends entirely on what’s causing it and how low your platelet count has dropped. A normal platelet count ranges from 150,000 to 400,000 per microliter of blood. Mild cases (100,000 to 150,000) often need nothing more than monitoring, while severe cases (below 50,000) typically require active treatment to prevent dangerous bleeding.
Why the Cause Matters More Than the Number
Thrombocytopenia isn’t a single disease. It’s a lab finding with dozens of possible causes, and the right treatment hinges on identifying the right one. Your body might be destroying platelets faster than it can make them (as in immune thrombocytopenia), your bone marrow might not be producing enough (as with chemotherapy or bone marrow disorders), or platelets might be getting trapped in an enlarged spleen due to liver disease. Each scenario calls for a different approach.
Sometimes the fix is as straightforward as stopping a medication. Heparin is the most common drug to trigger immune-related platelet destruction, but chemotherapy drugs, valproic acid (a seizure medication), NSAIDs like ibuprofen, certain antibiotics, statins, and even quinine can all drive counts down. When a medication is the culprit, platelet counts usually recover within one to two weeks of stopping the offending drug.
Treatment for Immune Thrombocytopenia (ITP)
ITP is one of the most common reasons people need active treatment for low platelets. In this condition, your immune system mistakenly tags platelets for destruction. Not everyone with ITP needs treatment right away. If your count is above 30,000 and you’re not bleeding, your doctor may recommend watchful waiting.
When treatment is needed, corticosteroids are the standard first step. These work by dialing down the immune response that’s destroying your platelets. Most adults start on a course of prednisone taken daily for several weeks, then gradually tapered, or a short four-day burst of dexamethasone. Many people see their platelet count rise within the first week or two. Another option for a rapid boost is intravenous immunoglobulin (IVIG), which is given as a single infusion and can raise platelet counts within 24 to 48 hours, making it especially useful before surgery or during active bleeding.
When First-Line Treatment Isn’t Enough
If corticosteroids don’t produce a lasting response, or if platelet counts drop again after tapering, several second-line options exist. Medications called TPO receptor agonists (romiplostim, eltrombopag, and avatrombopag) take a different approach entirely. Instead of trying to stop platelet destruction, they stimulate your bone marrow to ramp up platelet production. Romiplostim is given as a weekly injection under the skin, while eltrombopag and avatrombopag are daily pills. These are FDA-approved for adults and children with ITP who haven’t responded adequately to corticosteroids, immunoglobulin, or splenectomy.
Rituximab, which works by depleting the immune cells responsible for making the antibodies that attack your platelets, is another option for refractory cases. In one analysis of 249 patients with hard-to-treat ITP, about 42% achieved a complete response with rituximab alone. Fostamatinib, a newer oral medication, blocks a different step in the process: it interferes with the mechanism immune cells use to engulf and destroy antibody-coated platelets. In clinical trials of patients with chronic refractory ITP, up to 43% had an overall response.
Splenectomy, the surgical removal of the spleen, used to be a go-to second-line treatment. The spleen is where most antibody-coated platelets are filtered out and destroyed, so removing it can produce durable remissions. It’s still an option, but doctors now tend to try medications first and reserve splenectomy for cases where drugs haven’t worked or aren’t tolerated.
Liver Disease and Low Platelets
Chronic liver disease is a very common cause of thrombocytopenia. The liver produces thrombopoietin, the hormone that signals your bone marrow to make platelets. A damaged liver makes less of it. On top of that, an enlarged spleen (a frequent complication of liver disease) traps and pools platelets, pulling them out of circulation.
For people with liver disease who need a medical procedure, avatrombopag and lusutrombopag are specifically approved to temporarily raise platelet counts beforehand. These are taken as short oral courses in the days leading up to the procedure, reducing the need for platelet transfusions.
Platelet Transfusions
Platelet transfusions are reserved for specific situations, not used as a routine treatment for most causes of thrombocytopenia. Updated 2025 guidelines from the AABB provide clear thresholds. For patients on chemotherapy or undergoing stem cell transplant who aren’t actively bleeding, transfusion is recommended when the count drops below 10,000. Before a lumbar puncture, the threshold is 20,000. Before major surgery, it’s 50,000. Surgery involving the brain or eyes typically requires a count of at least 100,000.
In ITP specifically, transfusions are generally avoided unless there’s life-threatening bleeding. The same immune process that destroys your own platelets will also destroy transfused ones, so the benefit is fleeting. When transfusion is necessary in ITP emergencies, it’s usually combined with IVIG and high-dose corticosteroids to slow the destruction.
Thrombocytopenia During Pregnancy
About 10% of all pregnancies involve some degree of thrombocytopenia. The most common type, gestational thrombocytopenia, accounts for the majority of cases. It typically appears in the second or third trimester, keeps platelet counts above 80,000, and resolves on its own after delivery. It doesn’t increase the risk of bleeding for the mother or baby, and it doesn’t require treatment, just periodic monitoring.
ITP is the most common cause when platelet counts drop below 50,000 in the first or second trimester. It’s treated with the same corticosteroids and IVIG used outside of pregnancy, though medication choices are made carefully with fetal safety in mind. Platelet counts below 80,000 in early pregnancy, or a rapid decline at any point, should prompt investigation beyond gestational thrombocytopenia.
More urgent pregnancy-related causes include preeclampsia and HELLP syndrome, both of which can develop after 20 weeks. HELLP syndrome, characterized by platelet counts below 100,000 along with elevated liver enzymes and destruction of red blood cells, requires urgent delivery regardless of gestational age. Acute fatty liver of pregnancy, though rare, also demands early delivery.
Living With Low Platelets
If you have ongoing thrombocytopenia, a few practical adjustments can meaningfully reduce your bleeding risk. Avoid aspirin, ibuprofen, and other NSAIDs, which impair whatever platelet function you do have. Supplements like ginkgo biloba can have the same effect. Quinine-containing beverages (tonic water, for example) may worsen platelet counts in some people.
Activity restrictions depend on your count. Above 50,000, you should be cautious with contact sports but can generally stay active. Below 10,000, contact sports and high-impact activities should be completely avoided. At any count, practical steps like using a soft-bristled toothbrush, wearing shoes around the house, and being careful with sharp objects help prevent the kind of minor injuries that become a bigger deal when your platelets are low.
Know the warning signs that bleeding may be escalating: new clusters of tiny red or purple dots on the skin (petechiae), unexplained bruising, bleeding gums, blood in urine, or purple spots inside your mouth. Oral purpura and blood in the urine can sometimes precede more serious hemorrhage and deserve prompt evaluation.